| Blog results | Results 1 - 10 of about 28,060 for pancreatic cancer melanoma. (0.27 seconds) |
| Sorted by relevance Sort by date |
| 10 Nov 2009 by pillscribe Abraxane is currently in various stages of investigation for the treatment of the following cancers: expanded applications for metastatic breast, non-small cell lung, malignant melanoma and pancreatic cancer. ... DWS Pill Scribe - http://www.dancewithshadows.com/pillscribe/ - References [ More results from DWS Pill Scribe ] |
| 12 hours ago by admin Pink: Breast Cancer Light Blue: Prostate Cancer Teal: Ovarian/Uterine Cancer Gold: Childhood Cancers Grey: Brain Cancer Green: Kidney Cancer Dark Blue: Colon Cancer Yellow: Liver Cancer Purple: Pancreatic Cancer Black: Melanoma (Skin ... USA Information - http://us.promo.web.id/ |
| 20 Nov 2009 by Ani WASHINGTON - People with rare pancreatic cancer, called pancreatic neuroendocrine tumours (PNTs), might live longer if treated with radiation therapy, says a study. ... "Results of this trial now confirm the place of radiation therapy in the management of patients who have high risk features following surgery for melanoma involving the lymph nodes," said Bryan Burmeister, M.D., lead author of the study and a radiation oncologist at Princess Alexandra Hospital in Brisbane, ... Health News - http://blog.taragana.com/health/ [ More results from Health News ] |
| 9 Nov 2009 ABRAXANE Receives Orphan Drug Status for the Treatment of Pancreatic Cancer and Stage IIB-IV Melanoma, : Abraxis BioScience, Inc. announced that the Office of Orphan Products Development of the Food and Drug Administration (FDA) has ... Bionity.COM News - http://www.bionity.com/news/e/ |
| 5 Nov 2009 Abraxis BioScience was granted orphan drug designation by the FDA for its drug candidate, Abraxane for Injectable Suspension (paclitaxel albumin [human]-bound particles for injectable suspension) for the treatment of pancreatic cancer ... Latest articles from MPR - http://www.empr.com/ - References [ More results from Latest articles from MPR ] |
| 21 Nov 2009 by admin Names of Cancers Lung Cancer Bladder Cancer Colon and Rectal Cancer Breast Cancer Endometrial Cancer Kidney (Renal Cell) Cancer Non- Hodgkin Lymphoma Pancreatic Cancer Skin Cancer Non-melanoma thyroid Cancer Prostrate Cancer Leukemia ... Pinoy Healthcare - http://www.pinoyhealthcare.com/ |
| 7 Nov 2009 "As we advance our pivotal clinical trials of ABRAXANE in pancreatic cancer and melanoma, we look forward to the potential of bringing a new treatment option to patients with these difficult to treat cancers," said Lonnie Moulder, ... Nanotechnology Now Recent News - http://www.nanotech-now.com/ - References [ More results from Nanotechnology Now Recent News ] |
| 5 Nov 2009 Previous clinical trials have enrolled patients with breast cancer, melanoma, head and neck cancer and pancreatic cancer, with indications of clinical activity being observed in each. The Company recently commenced a Phase 3 study in ... Drugs.com - Clinical Trials - http://www.drugs.com/clinical_trials.html [ More results from Drugs.com - Clinical Trials ] |
| 6 Nov 2009 ... drug designation to the chemotherapy agent ABRAXANE for Injectable Suspension (paclitaxel protein-bound particles for injectable suspension) (albumin-bound) for the treatment of pancreatic cancer as well as stage IIB-IV melanoma. ... Current R&D of Pharmaceutical - http://www.cradop.com/component/content/frontpage.html |
| 10 Nov 2009 by rahul This modify of pancreatic cancer is rare. The vast majority of pancreatic cancer cases occur when the cells that distinction the pancreatic ducts begin ontogeny discover of control. This identify of growth is known as an exocrinal tumor ... Adenocarcinoma cancer - http://adenocarcinomacancer.blogspot.com/ |
Stay up to date on these results:
| Google Home - About Google Blog Search Beta - Information for Blog Authors |